Unapproved Prescription Drugs: Compliance Actions by Private Label Distributors
Firms
- Accentia Biopharmaceuticals, Inc.
- Allegis Pharmaceuticals, LLC
- Breckenridge Pharmaceuticals, LLC
- Centrix Pharmaceuticals, Inc.
- Cornerstone Biopharma, Inc.
- Deston Therapeutics, LLC
- Edwards Pharmaceuticals, Inc.
- Everett Laboratories, Inc.
- Jaymac Pharmaceuticals, LLC
- Larken Laboratories
- Magna Pharmaceuticals, Inc.
- Poly Pharmaceuticals, Inc.
- Portal Pharmaceuticals, Inc.
- Tiber Laboratories
- Unisource, Inc.
- Vertical Pharmaceuticals, Inc.
- Victory Pharma, Inc.
- Vision Pharma, LLC
- Wraser Pharmaceuticals
- Zyber Pharmaceuticals, Inc.
Accentia Biopharmaceuticals, Inc.
- Warning Letter (Issued November 13, 2009)
- Warning Letter (Issued November 13, 2009)
Breckenridge Pharmaceuticals, Inc.
- Warning Letter (Issued February 9, 2010)
- Warning Letter (Issued February 24, 2010)
- Warning Letter (Issued November 13, 2009)
- Warning Letter (Issued February 5, 2010)
- FDA News: U.S. Marshals seize Auralgan Otic Solution (Issued February 16, 2011)
- Warning Letter (Issued February 8, 2010)
- Warning Letter (Issued November 13, 2009)
- Warning Letter (Issued February 8, 2010)
- Warning Letter (Issued November 13, 2009)
- Warning Letter (Issued February 8, 2010)
- Warning Letter (Issued February 8, 2010)
- Warning Letter (Issued February 2, 2010)
- Warning Letter (Issued November 13, 2009)
- Warning Letter (February 17, 2010)
Vertical Pharmaceuticals, Inc.
- Warning Letter (Issued February 18, 2010)
- Warning Letter (Issued November 13, 2009)
- Warning Letter (Issued April 29, 2010)
- Warning Letter (Issued November 13, 2009)
- Warning Letter (Issued November 13, 2009)